Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Shareholders that lost money on Merck & Co., Inc. (MRK) should contact Levi & Korsinsky about pending Class Action - MRK
If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities ...
How Americans' changing views on health paved the way for RFK Jr.
The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as secretary of health and human services.
Merck stock touches 52-week low at $85.71 amid market challenges
Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.
Pharmaceutical Technology2d
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
Pharmaceutical Technology2d
Health Canada approves MSD’s Keytruda for NSCLC stages
Health Canada has approved MSD’s anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...
24/7 Wall St3d
Jim Cramer Says These 2 Large Cap Dividend Stocks Are Hot February Buys
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...